Early Re-intervention in Infants and Small Children After Correction of Tetralogy of Fallot

Early Re-intervention in Infants and Small Children After Correction of Tetralogy of Fallot: Prospective Analysis of Myocardial Benefit Using Cardiac MRI and Echocardiography

Tetralogy of Fallot is one of the most frequent congenital heart malformations. In many cases re-interventions, surgical or catheter-based, are necessary after the repair of tetralogy of Fallot in infancy. At present, informations in the literature about the myocardial benefit and the timing of re-interventions are missing in this age group. On the other hand, Fallot patients are dependent on solid criteria for re-interventions, because further interventions like replacement of the pulmonary valve or balloon dilatations of peripheral pulmonary stenoses are common.

The objective of this study is to assess the benefit of such interventions for the right ventricular function. By performing extensive standardised examinations (including MRI, echocardiography, tissue Doppler,,3D-echocardiography, holter monitoring and quality of life assessments) before and 6 to 9 months after the re-intervention data of the right ventricular function are collected. Based on these quantitative data predictive parameters concerning the right ventricular recovery and information about the time of re-intervention should be determined.

Study Overview

Status

Completed

Conditions

Detailed Description

In the repair of tetralogy of Fallot, pulmonary insufficiency used to be tacitly accepted as a result of extensive transannular patching (TAP) and considered unobjectionable. In fact, this is well tolerated during the first postoperative years, but today there is increasing evidence that the resulting chronic volume stress to the right ventricle is harmful on the long run, in particular if there are stenoses of the pulmonary artery in addition. Such stenoses, partly due to distortions after shunt surgery, together with pulmonary insufficiency, lead to a combined volume and pressure load of the right ventricle. The chronic volume stress results in a decrease in biventricular function and exercise tolerance, associated with increasing electrical instability with frequent, mostly ventricular, dysrhythmias. This constellation brings about a significantly increased risk of cardiac death.

Pulmonary valve replacement can improve haemodynamics, exercise tolerance and dysrhythmia. However, it is still unclear, which criteria best indicate the need for re-intervention, such as balloon dilatations of peripheral pulmonary stenoses, and what may be the best point in time in infancy.

The objective of this study is to assess the effectiveness of such interventions to the right ventricular function in small children. The data obtained are supposed to determine predictive parameters of the right ventricular recovery and to help to establish criteria for the necessity and time of re-intervention.

Study Type

Observational

Enrollment (Actual)

93

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Berlin, Germany, D-13353
        • Deutsches Herzzentrum Berlin
      • Berlin, Germany, D-13353
        • Universitätsklinikum Charite, Campus Virchow-Klinikum, Otto-Heubner-Centrum für Kinder- und Jugendmedizin
    • Baden-Wuerttemberg
      • Freiburg, Baden-Wuerttemberg, Germany, D-79106
        • Universitätsklinikum Freiburg, Klinik III Päd. Kardiologie
      • Tuebingen, Baden-Wuerttemberg, Germany, D-72076
        • Universitätsklinikum Tuebingen, Klinik für Kinderheilkunde und Jugendmedizin
    • Bavaria
      • Munich, Bavaria, Germany, D-80636
        • Deutsches Herzzentrum Muenchen
    • Lower Saxony
      • Hannover, Lower Saxony, Germany, D-30625
        • Medizinische Hochschule Hannover, Pädiatrische Kardiologie und Intensivmedizin
    • North Rhine-Westphalia
      • Bad Oeynhausen, North Rhine-Westphalia, Germany, D-32545
        • Herz- und Diabeteszentrum Nordrhein-Westfalen
      • Duisburg, North Rhine-Westphalia, Germany, D-47137
        • Herzzentrum Duisburg, Kinderkardiologie
      • Essen, North Rhine-Westphalia, Germany, D-45122
        • Universitätsklinikum Essen, Klinik für Kinderkardiologie
      • Muenster, North Rhine-Westphalia, Germany, D-48149
        • Universitätsklinikum Muenster, Klinik für Kinderkardiologie
      • Sankt Augustin, North Rhine-Westphalia, Germany, D-53757
        • Deutsches Kinderherzzentrum St. Augustin
    • Saarland
      • Homburg/Saar, Saarland, Germany, D-66421
        • Universitätsklinikum des Saarlandes, Klinik für Pädiatrische Kardiologie
    • Saxony
      • Leipzig, Saxony, Germany, D-04289
        • Herzzentrum Leipzig, Klinik für Kinderkardiologie
    • Schleswig-Holstein
      • Kiel, Schleswig-Holstein, Germany, D-24105
        • Universitätsklinikum Schleswig-Holstein Campus Kiel, Klinik für Kinderkardiologie

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 7 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

children, <8 years, with tetralogy of Fallot

Description

Inclusion Criteria:

  • Written informed consent of the patient's legal representatives
  • Patients with tetralogy of Fallot (including pulmonary atresia with vsd) after corrective operation
  • Patients < 8 years with corrective surgery and necessary re-intervention (e.g.cardiac catheter intervention or re-operation )

Exclusion Criteria:

  • DORV (if there is another VSD than subaortic)
  • Associated severe heart defects (e. g. AV canal)
  • Other clinically relevant diseases, such as malignant tumor (in the investigating physician's assessment)
  • MRI contraindication, e.g. cardiac pacemaker, implanted neurostimulators and other magnetizable foreign bodies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Samir Sarikouch, MD, Medizinische Hochschule Hannover, Lower Saxony

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2007

Primary Completion (ACTUAL)

September 1, 2011

Study Completion (ACTUAL)

June 1, 2012

Study Registration Dates

First Submitted

September 26, 2007

First Submitted That Met QC Criteria

September 26, 2007

First Posted (ESTIMATE)

September 27, 2007

Study Record Updates

Last Update Posted (ESTIMATE)

June 6, 2012

Last Update Submitted That Met QC Criteria

June 5, 2012

Last Verified

October 1, 2010

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tetralogy of Fallot

3
Subscribe